Cystic fibrosis year in review 2024
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2025.02.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Amel Alameeri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of adult Pulmonary medicine, ST Shaikh Tahnoon medical City Hospital, Alain, AbuDhabi, UAE. Electronic address: aeamiri@seha.ae. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
The year 2024 marks a pivotal moment in the field of cystic fibrosis (CF) treatment, characterised by significant advancements in clinical care and an expanding body of literature on CF transmembrane conductance regulator (CFTR) modulators. These CFTR therapies have transformed the landscape of CF management, offered systemic benefits, and established new guidelines for assessing clinical manifestations and therapies. Additionally, progress has been made in newborn screening (NBS), diagnosis, and understanding outcomes for individuals with CF-related metabolic syndrome or inconclusive diagnostic results. However, amidst these clinical milestones, disparities in global access to CFTR modulators (CFTRm) persist, threatening to exacerbate existing inequities in CF care. This review provides a focused overview of the most impactful articles from 2024, highlighting both the clinical advancements and the pressing global accessibility challenges that define this transformative era in CF research and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of adult Pulmonary medicine, ST Shaikh Tahnoon medical City Hospital, Alain, AbuDhabi, UAE. Electronic address: aeamiri@seha.ae.
- Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ihsan Dogramaci Children's Hospital, Ankara, Türkiye. Electronic address: caprazburcu@gmail.com.
- Cystic fibrosis center, Cardiothoracovascular Department, AOUI Verona, Verona, Italy. Electronic address: Francesca.lucca@aovr.veneto.it.
- Cystic Fibrosis Centre Peadiatrics and Adult Zagreb, University Hospital Centre Zagreb, Croatia. Electronic address: ivan_bambir@hotmail.com.
- Department of Pediatric and Cystic fibrosis, Polanki Children's Hospital, Gdańsk, Poland. Electronic address: p.famulska@gmail.com.
- Pediatric Cystic fibrosis Center, Department of Pediatric Pulmonology, Instituto Fernandes Figueira/FIOCRUZ, Rio de Janeiro, RJ, Brazil. Electronic address: renatawfc@gmail.com.
Zitieren
APA
Alameeri, A., Yavuz, B. C., Lucca, F., Bambir, I., Famulska, P., & Cohen, R. W. F. (2025). Cystic fibrosis year in review 2024. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.02.012
Vancouver
Alameeri A, Yavuz BC, Lucca F, Bambir I, Famulska P, Cohen RWF. Cystic fibrosis year in review 2024. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.02.012
BibTeX
@article{Alameeri2025,
author = {Alameeri, Amel and Yavuz, Burcu Capraz and Lucca, Francesca and Bambir, Ivan and Famulska, Paulina and Cohen, Renata Wrobel Folescu},
title = {Cystic fibrosis year in review 2024},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2025.02.012}
}
EUVIMED